The pharmaceutical industry is at a critical inflection point in social media strategy. As traditional KOL models evolve toward creator partnerships and micro-influencer collaborations, marketers face mounting questions about regulatory compliance, strategic integration, and measurement. This intimate discussion brings together brand leaders and their industry partners to tackle the most pressing challenges: navigating FDA uncertainty around influencer engagement, determining best practices for HCP and patient creators, integrating social influence into broader media strategies, and proving ROI beyond vanity metrics. From Reddit’s untapped potential to TikTok’s patient education promise, we’ll explore how pharmaceutical companies can crack the social code while maintaining compliance and authenticity.